Eradicating chronic ear, nose, and throat infections: A systematically conducted literature review of advances in biofilm treatment

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 3, 2011, Pages 338-347

  Smith, Angelia ^a   Buchinsky, Farrel Joel ^a   Post, J Christopher ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Biofilm; ENT; Otitis; Review; Rhinitis; Sinusitis; Tonsil; Treatment; Voice

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CRYSTAL VIOLET; DOXYCYCLINE; ERYTHROMYCIN; FUROSEMIDE; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PROBIOTIC AGENT; PSEUDOMONIC ACID; RIFAMPICIN; SURFACTANT; THIAMPHENICOL; TOBRAMYCIN; TRICLOSAN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BIOFILM; DRUG EFFECT; EAR INFECTION; HUMAN; NONHUMAN; NOSE INFECTION; OTORHINOLARYNGOLOGY; PHARYNGITIS; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; ANIMAL; BACTERIAL INFECTION; CHRONIC DISEASE; COCHLEA PROSTHESIS; EAR NOSE THROAT DISEASE; MICROBIOLOGY; SINUSITIS; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; CHRONIC DISEASE; COCHLEAR IMPLANTS; HUMANS; OTORHINOLARYNGOLOGIC DISEASES; SINUSITIS; TREATMENT OUTCOME;

EID: 79959797242     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810391620     Document Type: Review

References (49)

1. Foreman A, Psaltis AJ, Tan LW, et al. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:556-561.
2. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202-211. (Pubitemid 44050374)
3. Jarszak EM, Sampson EM, Antonelli PJ. Effect of ossicular prosthesis biofilms on middle ear scarring and hearing outcomes. Otol Neurotol. 2009;30:1191-1195.
4. Barakate M, Beckenham E, Curotta J, et al. Bacterial biofilm adherence to middle-ear ventilation tubes: scanning electron micrograph images and literature review. J Laryngol Otol. 2007;121:993-997. (Pubitemid 351650454)
5. Macassey E, Dawes P. Biofilms and their role in otorhinolaryngological disease. J Laryngol Otol. 2008;122:1273-1278.
6. Keays T, Ferris W, Vandemheen KL, et al. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations. J Cyst Fibros. 2009;8:122-127.
7. Bartley J, Young D. Ultrasound as a treatment for chronic rhinosinusitis. Med Hypotheses. 2009;73:15-17.
8. Ansari NN, Naghdi S, Farhadi M, et al. A preliminary study into the effect of low-intensity pulsed ultrasound on chronic maxillary and frontal sinusitis. Physiother Theory Pract. 2007;23:211-218. (Pubitemid 47237757)
9. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384. (Pubitemid 28438523)
10. Kondoh K, Hashiba M, Baba S. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol Suppl. 1996;525:56-60. (Pubitemid 26332363)
11. Kondoh K, Hashiba M. Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa. Nippon Jibiinkoka Gakkai Kaiho. 1998;101:25-36.
12. Free RH, van der Mei HC, Dijk F, et al. Biofilm formation on voice prostheses: influence of dairy products in vitro. Acta Otolaryngol. 2000;120:92-99. (Pubitemid 30434139)
13. Elving GJ, van der Mei HC, Busscher HJ, et al. Antimicrobial activity of synthetic salivary peptides against voice prosthetic microorganisms. Laryngoscope. 2000;110:321-324. (Pubitemid 30090870)
14. van der Mei HC, Free RH, Elving GJ, et al. Effect of probiotic bacteria on prevalence of yeasts in oropharyngeal biofilms on silicone rubber voice prostheses in vitro. J Med Microbiol. 2000;49:713-718. (Pubitemid 30623903)
15. Free RH, van der Mei HC, Elving GJ, et al. Influence of the Provox flush, blowing, and imitated coughing on voice prosthetic biofilms in vitro. Acta Otolaryngol. 2003;123:547-551. (Pubitemid 36609776)
16. Oosterhof JJ, Elving GJ, Stokroos I, et al. The influence of antimicrobial peptides and mucolytics on the integrity of biofilms consisting of bacteria and yeasts as affecting voice prosthetic air flow resistance. Biofouling. 2003;19:347-353. (Pubitemid 38106504)
17. Rodriguez L, van der Mei HC, Teixeira J, et al. Influence of biosurfactants from probiotic bacteria on formation of biofilms on voice prostheses. Appl Environ Microbiol. 2004;70:4408-4410. (Pubitemid 38969794)
18. Schwandt LQ, van Weissenbruch R, Stokroos I, et al. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 2004:124:726-731. (Pubitemid 39093358)
19. Schwandt LQ, van Weissenbruch R, van der Mei HC, et al. Effect of dairy products on the lifetime of Provox2 voice prostheses in vitro and in vivo. Head Neck. 2005;27:471-477. (Pubitemid 40770815)
20. Slinger R, Chan F, Ferris W, et al. Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis. 2006;56:247-253. (Pubitemid 44648594)
21. Cross JL, Ramadan HH, Thomas JG. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture. Otolaryngol Head Neck Surg. 2007;137:21-26. (Pubitemid 46964830)
22. Desrosiers M, Bendauah Z, Barbeau J. Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. Am J Rhinol. 2007;21:149-153. (Pubitemid 46846342)
23. Desrosiers M, Myntti M, James G. Methods for removing bacterial biofilms: in vitro study using clinical chronic rhinosinusitis specimens. Am J Rhinol. 2007;21:527-532. (Pubitemid 350099759)
24. Oxley KS, Thomas JG, Ramada HH. Effect of ototopical medications on tympanostomy tube biofilms. Laryngoscope. 2007;117:1819-1824. (Pubitemid 47508716)
25. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008;22:34-37. (Pubitemid 351310950)
26. Kaji C. Antimicrobial effect of fluoroquinolones for the eradication of nontypeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med. 2008;214:121-128. (Pubitemid 351513544)
27. Ha KR, Psaltis AJ, Butcher AR, et al. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 2008;118:535-540. (Pubitemid 351640625)
28. Krespi YP, Stoodley P, Hall-Stoodley L. Laser disruption of biofilms. Laryngoscope. 2008;118:1168-1173.
29. Starner TD, Shrout JD, Parsek MR, et al. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother. 2008;52:137-145.
30. Wang EW, Agostini G, Olomu O, et al. Gentian violet and ferric ammonium citrate disrupt Pseudomonas aeruginosa biofilms. Laryngoscope. 2008;118:2050-2056.
31. Wang D, Wang Y, Liu YN. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae. Chin Med J. 2009;122:1305-1310.
32. Alandejani T, Marsan J, Ferris W, et al. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Head Neck Surg. 2009;141:114-118.
33. Parra A, Ponte C, Cenjor C, et al. Effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae strains with different susceptibilities to amoxicillin. Antimicrob Agents Chemother. 2004;48:860-866. (Pubitemid 38280336)
34. Chennupati SK, Chiu AG, Tamashiro E, et al. Effects of an LL- 37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy. 2009;23:46-51.
35. Chiu AG, Antunes MB, Palmer JN, et al. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother. 2007;59;1130-1134. (Pubitemid 47073323)
36. Le T, Psaltis A, Tan LW, et al. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis. Am J Rhinol. 2008:22:560-567.
37. Kayama C, Goto Y, Shimoya S, et al. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus. J Otolaryngol. 2006;35:364-366.
38. Macchi A, Ardito F, Marchese A, et al. Efficacy of N-acetylcysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms. J Chemother. 2006;8:507-513.
39. Solares CA, Batra PS, Hall GS, et al. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol. 2006;27:161-165.
40. Erlich GD, Veeh R, Wang X, et al. Mucosal biofilm formation on the middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002;287:1710-1715. (Pubitemid 34289224)
41. Galli J, Calò L, Ardito F, et al. Biofilm formation by Haemophilus influenzae isolated from adenotonsil tissue samples, and its role in recurrent adenotonsillitis. Acta Otorhinolaryngol Ital. 2007;27:134-138.
42. Brook I. The role of bacteria in chronic rhinosinusitis. Otolaryngol Clin North Am. 2005:38:1171-1192. (Pubitemid 41737830)
43. Busscher HJ, Geertsema-Doornbusch GI, van der Mei HC. Adhesion to silicone rubber of yeasts and bacteria isolated from voice prostheses: influence of salivary conditioning films. J Biomed Mater Res. 1997;34:201-209.
44. Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80:265-269.
45. Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev. 2002;3:128-134. (Pubitemid 35331506)
46. Gales G, Penninckx M, Block JC, Leroy P. Role of glutathione metabolism status in the definition of some cellular parameters and oxidative stress tolerance of Saccharomyces cerevisiae cells growing as biofilms. FEMS Yeast Res. 2008;8:667-675.
47. Enami S, Hoffmann MR, Colussi AJ. Ozone oxidized glutathione to sulfonic acid. Chem Res Toxicol. 2009;22:35-40.
48. Free RH, Elving GJ, van der Mei HC, et al. Caffeinated soft drinks reduce bacterial prevalence in voice prosthetic biofilms. Biofouling. 2000;16:69-76.
49. Free RH, Busscher HJ, Elving GJ, et al. Biofilm formation on voice prostheses: in vitro influence of probiotics. Ann Otol Rhinol Laryngol. 2001;110:946-951. (Pubitemid 32979989)